![CMS-medicare-AHA-comment](/sites/default/files/2018-05/CMS-medicare-AHA-comment.jpg)
The Food and Drug Administration approved dexmedetomidine hydrochloride in 0.9% sodium chloride injection for the sedation of initially intubated and mechanically ventilated patients in an intensive-care setting and of non-intubated patients prior to and/or during surgical and other procedures.